
Join to View Full Profile
5050 NE Hoyt StSte 540Portland, OR 97213
Phone+1 503-215-6600
Dr. Paiva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Cody Paiva, DO, is an Internal Medicine specialist based in Portland, OR. He completed his residency in Internal Medicine from 2020 to 2023 at Providence Health & Services - Oregon/St Vincent Hospital and Medical Center, following his graduation from Pacific Northwest University of Health Sciences College of Osteopathic Medicine in 2020. He holds a Bachelor of Science in Microbiology from the University of Vermont and a Master of Public Health from Eastern Washington University. Dr. Paiva has contributed to multiple publications, with several of his studies focusing on B-cell lymphoma and leukemia, which have garnered citations from other works.
Education & Training
- Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterResidency, Internal Medicine, 2020 - 2023
- Eastern Washington UniversityMPH, Public Health, 2017 - 2020
- Pacific Northwest University of Health Sciences College of Osteopathic MedicineClass of 2020
- University of VermontBS, Microbiology, 2009 - 2013
Certifications & Licensure
- OR State License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 32 citationsTargeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cellsScott R Best, Taylor Hashiguchi, Adam Kittai, Nur Bruss, Cody Paiva
Blood Advances. 2019-01-08 - 33 citationsCyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma.Taylor Hashiguchi, Nur Bruss, Scott R Best, Vi Lam, Olga V. Danilova
Molecular Cancer Therapeutics. 2019-01-01 - 28 citationsSYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.Cody Paiva, Taylor Rowland, Bhargava Sreekantham, Claire Godbersen, Scott R Best
Haematologica. 2017-11-01
Journal Articles
- . Targeting ubiquitin-activating enzyme induces ER stress mediated apoptosis in B-cell lymphoma cellsBest SR, Hashiguchi T, Kittai A, Briss N, Paiva CJ, Okada C, Liu T, Berger A, Danilov AV, Blood Advances, 1/2019
- Electronic Health Record Implementation: A Quality Assurance Assessment from a Free Clinic PerspectiveAsmussen A, Paiva CJ, Hepner E, Garibay A, McCarroll ML, J Comm Med Health Ed, 9/7/2017
- Pevonedistat, a Nedd8-activating Enzyme Inhibitor, Sensitizes Neoplastic B-Cells to Death Receptor-Mediated ApoptosisPaiva C, Godbersen JC, Rowland T, Danilova OV, Danes C, Berger A, Danilov AV, Oncotarget, 3/2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: